Viemed Healthcare (VMD) Net Income towards Common Stockholders (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Net Income towards Common Stockholders data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders changed 0.11% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.4 million (up 22.87% YoY) and the FY2025 annual result came in at $15.4 million, up 34.77% from the prior year.
• Net Income towards Common Stockholders eased to $2.7 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $5.8 million in Q4 2025 to a low of $967000.0 in Q2 2022.
• A 5-year average of $2.7 million and a median of $2.7 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders sank 41.03% — and 2023, when it surged 176.68%.
• Tracing VMD's Net Income towards Common Stockholders over 5 years: stood at $2.4 million in 2022, then soared by 42.62% to $3.5 million in 2023, then gained by 27.24% to $4.4 million in 2024, then soared by 31.46% to $5.8 million in 2025, then slumped by 53.35% to $2.7 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $2.7 million (Q1 2026), $5.8 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.